Anesthesia Drug Targets
Anesthesia Drug Targets - Related Videos
11:56
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
0 Views •
Cited by 4 •
2013
Acquired resistance to antibiotics is a major public healthcare problem and is presently ranked by the WHO as one of the greatest threats to human life. Here we describe the use of cantilever technology to quantify antibacterial resistance, critical to the discovery of novel and powerful agents against multidrug resistant bacteria.
14:01
Anesthesia Induction and Maintenance
0 Views •
2016
Source: Kay Stewart, RVT, RLATG, CMAR; Valerie A. Schroeder, RVT, RLATG. University of Notre Dame, IN The Guide for the Care and Use of Laboratory Animals ("The Guide") states that pain assessment and alleviation are integral components of the veterinary care of laboratory animals. The definition of anesthesia is the loss of feeling or sensation. It is a dynamic event involving changes in anesthetic depth with respect to an animal's metabolism, surgical stimulation, or variations in the...
01:26
Targets for Drug Action: Overview
0 Views •
2023
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes. Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:29
Pharmacogenomics: Identification of New Drug Targets
0 Views •
2026
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
03:30
Targeted Drug Delivery in a Mouse Model via Cisterna Magna Injection
0 Views •
2025
Source: Zamboni, M., et al., Induction of Leptomeningeal Cells Modification Via Intracisternal Injection. J. Vis. Exp. (2020)This video demonstrates the procedure of delivering an inducer drug into the cisterna magna of an anesthetized mouse. The injection selectively induces fluorescent marker expression in brain surface cells accessible via cerebrospinal fluid, confirmed by fluorescence imaging.
FAQs
Separating these target classes clarifies which molecular systems an anesthetic agent may affect. Receptors and ion channels can alter neuronal excitability and synaptic transmission, whereas enzymes and signaling proteins may provide links to immune or tumor-cell pathways. This distinction helps cancer researchers interpret effects that extend beyond loss of sensation or altered consciousness.
Anesthetic modulation of GABA or glycine pathways can strengthen inhibitory signaling, while ion-channel effects can alter neuronal excitability and synaptic transmission. Together, these mechanisms help explain changes in consciousness, sensation, and pain. In cancer research, identifying the relevant pathway or channel allows investigators to connect neural actions with possible non-neural signaling effects.
Ion channels regulate the electrical behavior of neurons, so changing their activity can modify excitability and synaptic communication. These effects help researchers distinguish how anesthetic agents influence neural function from how they may affect other molecular systems. That separation is useful when interpreting whether a cancer-related observation reflects anesthesia mechanisms or cellular signaling.
Signaling proteins may connect anesthetic exposure with immune or tumor-cell signaling, creating a molecular context for studying cancer-related effects. Their involvement does not establish a particular outcome by itself, but it identifies pathways that researchers can examine alongside neuronal targets. This supports investigations of inflammation, metastasis, tumor growth, and treatment responses.
Target profiling maps the receptors, ion channels, enzymes, and signaling proteins affected by anesthetic agents, then provides a framework for relating those targets to cancer-relevant processes. Researchers can use this information to examine whether perioperative exposure has plausible connections with inflammation, metastasis, tumor growth, or responses to treatment.
These studies can focus on inflammation, metastasis, tumor growth, and responses to treatment. The target information helps researchers investigate whether anesthetic exposure may influence such outcomes through immune or tumor-cell signaling, rather than treating all anesthetic effects as purely neurological. Findings can therefore connect molecular target activity with broader cancer research questions.
Identifying the molecular targets influenced by anesthetic agents helps researchers relate specific mechanisms to both desired neural effects and possible immune or tumor-cell signaling. This information supports studies aimed at selecting or evaluating anesthetic strategies in a cancer setting. The broader goal is to examine safety while considering potential effects on cancer-related outcomes.
Perioperative anesthetic exposure provides the context for examining how anesthesia-related molecular effects might intersect with cancer biology. Researchers can evaluate target activity alongside questions about inflammation, metastasis, tumor growth, and treatment response. This approach does not assume a single outcome; instead, it frames anesthesia mechanisms as variables to investigate in relation to cancer outcomes.